Table 1 Description of inclusion and exclusion criteria for the different treatment regimens

 Muscle hypertonicity is the primary component of spasticity

x

x

x

 The UL spasticity limits ADLs

x

x

x

 The patient had nonpharmacologic and/or pharmacologic spasticity treatment, with specific recommendations for botulinum toxin injection

x

x

x

 The patient has volition motor function in the UL

x

x

 The patient agrees to comply fully with the treatment regimen

x

(x)

 The patient is motivated to participate in intensive rehabilitation

x

(x)

 The patient has stable home care/assistance

x

(x)

 Functional score^a 1

x

 Functional score^a 2

x

x

 Functional score^a 3

x

x

(x)

 Functional score^a 4

x

(x)

(x)

 The patient must have residual shoulder mobility

x

 Severe cognitive impairments

x

x

 Mild cognitive impairments

x

 Severe contractures that hinder surgical benefit

x

(x)